Microbix Biosystems (TSE:MBX) Share Price Crosses Above Fifty Day Moving Average – Here’s Why

Microbix Biosystems Inc. (TSE:MBX) crossed above its 50 day moving average during trading on Tuesday. The stock has a 50 day moving average of C$0.30 and traded as high as C$0.30. Microbix Biosystems shares last traded at C$0.30, with a volume of 4,150 shares trading hands.

Microbix Biosystems Stock Down 3.3%

The company has a quick ratio of 5.57, a current ratio of 6.89 and a debt-to-equity ratio of 27.69. The company has a market cap of C$40.41 million, a P/E ratio of -8.19 and a beta of 0.41. The company has a fifty day moving average of C$0.30 and a 200 day moving average of C$0.27.

Microbix Biosystems (TSE:MBX) last posted its earnings results on Thursday, August 13th. The company reported C($0.01) earnings per share for the quarter. The firm had revenue of C$4.06 million during the quarter. Microbix Biosystems had a negative net margin of 31.72% and a negative return on equity of 18.83%. On average, research analysts anticipate that Microbix Biosystems Inc. will post 0.02 earnings per share for the current fiscal year.

Microbix Biosystems Company Profile

Microbix Biosystems Inc. creates proprietary biological products for human health, with over 120 skilled employees and revenues of C$ 18.6 million in its last reported fiscal year (2025). It enables the worldwide commercialization of diagnostic assays by making a wide range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs ¿ ) and reference materials (QUANTDx ¿ ) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows.